Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp reports results for the quarter ended in June - Earnings Summary

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 34 cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 37 cents per share.
* Revenue rose 232.2% to $12.20 million from a year ago; 
analysts expected $10.51 million. 
* Pulmonx Corp's reported EPS for the quarter was a loss of 34
cents​.
* The mean earnings estimate of analysts had risen by about 1.1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Pulmonx Corp shares had fallen by 8.8% this quarter and
lost 41.7% so far this year.
* The company reported a quarterly loss of $12.38 million.
* Wall Street's median 12-month price target for Pulmonx Corp is
$60.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 3 at 10:09 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Pulmonx

See all news